Compliance with the prescription of recommended medical therapy in trials comparing six versus 12 months or longer dual antiplatelet therapy: A systematic review and meta-analysis
Restricted accessResearch articleFirst published online October, 2019
Compliance with the prescription of recommended medical therapy in trials comparing six versus 12 months or longer dual antiplatelet therapy: A systematic review and meta-analysis
GwonHCHahnJYParkKW, et al.Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study. Circulation2012; 125: 505–513.
2.
Schulz-SchupkeSByrneRATen BergJM, et al.ISAR-SAFE: A randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting. Eur Heart J2015; 36: 1252–1263.
3.
Pinho-GomesACAzevedoLAhnJM, et al.Compliance with guideline-directed medical therapy in contemporary coronary revascularization trials. J Am Coll Cardiol2018; 71: 591–602.
4.
HahnJYSongYBOhJH, et al.6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): A randomised, open-label, non-inferiority trial. Lancet2018; 391: 1274–1284.
5.
ValgimigliMCampoGMontiM, et al.Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: A randomized multicenter trial. Circulation2012; 125: 2015–2026.
6.
BalderJWde VriesJKMulderDJ, et al.Time to improve statin prescription guidelines in low-risk patients?Eur J Prev Cardiol2017; 24: 1064–1070.
7.
LafeberMSpieringWVisserenFL, et al.Impact of switching from different treatment regimens to a fixed-dose combination pill (polypill) in patients with cardiovascular disease or similarly high risk. Eur J Prev Cardiol2017; 24: 951–961.
